Systematic reviews as a “lens of evidence”: Determinants of cost‐effectiveness of breast cancer screening-Reference-Cited by-同舟云学术

Systematic reviews as a “lens of evidence”: Determinants of cost‐effectiveness of breast cancer screening

Published:2019-09-30 Issue:18 Volume:8 Page:7846-7858
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Mandrik Olena¹²³^ORCID,Ekwunife Obinna Ikechukwu⁴⁵,Meheus Filip³,Severens Johan L. (Hans)¹⁶,Lhachimi Stefan⁵⁷,Uyl‐de Groot Carin A.¹⁶,Murillo Raul³⁸⁹

Affiliation:

1. Erasmus School of Health Policy & Management Erasmus University Rotterdam Rotterdam The Netherlands

2. Health Economic and Decision Science (HEDS) School of Health and Related Research (ScHARR), The University of Sheffield Sheffield UK

3. The section of Early Detection and Prevention International Agency for Research on Cancer Lyon France

4. Collaborative Research Group for Evidence‐Based Public Health Department of Prevention and Evaluation Leibniz Institute for Prevention Research and Epidemiology BIPS/University of Bremen Bremen Germany

5. Department of Clinical Pharmacy and Pharmacy Management Nnamdi Azikiwe University Awka Nigeria

6. Institute for Medical Technology Assessment (iMTA) Erasmus University Rotterdam Rotterdam The Netherlands

7. Institute for Public Health and Nursing Research—IPP Health Sciences Bremen University of Bremen Bremen Germany

8. Centro Javeriano de Oncología Hospital Universitario San Ignacio Bogotá Colombia

9. Faculty of Medicine Pontificia Universidad Javeriana Bogotá Colombia

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2498

Reference56 articles.

1. New evidence pyramid

2. WHO.Guidelines approved by the guidelines review committee WHO position paper on mammography screening.Geneva:World Health Organization;2014.

3. Systematic reviews as a ‘lens of evidence’: Determinants of benefits and harms of breast cancer screening

4. Breast Cancer Screening for Women at Average Risk

5. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A critical review and analysis of the context, current burden, and application of policy to improve cancer equity in Ghana;International Journal for Equity in Health;2023-12-08

2. Does Laterality in Breast Cancer still have the Importance to be Studied? A Meta-analysis of Patients with Breast Cancer;Current Medicinal Chemistry;2023-11-06

3. Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women;Current Oncology;2023-09-18

4. An artificial intelligence based app for skin cancer detection evaluated in a population based setting;npj Digital Medicine;2023-05-20

5. Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review;PharmacoEconomics;2023-03-08